Hypertension: An Overview

Meta-analyses of the beta-adrenergic blocker trials show a reduction in mortality of approximately 30 to 35%.4-7 The beta-adrenergic blockers that have been studied for chronic HF and have demonstrated a reduction in mortality include bisoprolol, carvedilol, and sustained release metoprolol succinate (refer to Appendix A for details of clinical ... ................
................